Poor Customer Data Management Costs Pharma Companies Money: Report 4/10/2024

AACR 2024: What Cancer Researchers Are Talking About 4/10/2024

Novo Inks $600M Deal with Metaphore to Develop Next-Gen Obesity Drugs 5/9/2024

Takeda Lowers Profit Outlook Amid Vyvanse Loss of Exclusivity, Eyes $900M Restructuring in 2024 5/9/2024

Women's Health: Where Politics and Science Meet 5/9/2024

Attovia Secures $105M Series B to Expand I&I Pipeline of Bispecific Antibodies 5/9/2024

Lisata’s Autologous T Cell Therapy Is Safe but Fails to Slow T1D Disease Progression, Trial Finds 5/9/2024

Bespoke Gene Therapy Consortium Targets AAVs for Rare Diseases 5/9/2024

Keytruda Strikes Out Again in Endometrial Cancer with Phase III Flop 5/9/2024

DEIB Evolves As Criticism, Changing Attitudes Continue 5/9/2024

Dry Promotions: Dealing With a Double-Edged Sword 5/9/2024

Top 5 Companies Hiring in the Boston Area 5/9/2024

ASGCT24: On the Ground in Baltimore 5/9/2024

The Next Frontier: Industrializing Cell Therapy Manufacturing 5/9/2024

Pfizer Eyes Broader Label for RSV Vaccine Abrysvo After Promising Phase III Data 4/9/2024

Nvelop and Seaport Raise $100M in Rounds, Tap Bluebird and Karuna Execs 4/9/2024

FDA Backs BrainStorm’s Design for Phase IIIb Trial in Early-Stage ALS 4/9/2024

EMA to Review Diabetes and Weight-Loss Drugs for Suicidal Ideation Risk 4/9/2024

AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report 4/9/2024

Regeneron’s Gene Therapy Shows ‘Dramatic’ Hearing Improvement in Deaf Kids 5/8/2024